Mectinsanbe 12 Adverse Reactions

Strongyloidiasis: Body as a Whole: asthenia/fatigue, abdominal pain.
Gastrointestinal: anorexia, constipation, diarrhea, nausea, vomiting.
Nervous System/Psychiatric: dizziness, somnolence, vertigo, tremor.
Skin: pruritus, rash, and urticaria.
The Mazzotti-type and ophthalmologic reactions associated with the treatment of onchocerciasis or the disease itself would not be expected to occur in strongyloidiasis patients treated with Ivermectin. (See Onchocerciasis as follows).
Onchocerciasis: Worsening of the following Mazzotti reactions during the first 4 days post-treatment were reported: arthralgia/synovitis, axillary lymph node enlargement and tenderness, cervical lymph node enlargement and tenderness, inguinal lymph node enlargement and tenderness, other lymph node enlargement and tenderness, pruritus, skin involvement including edema, papular and pustular or frank urticarial rash, and fever. (See Precautions).
The following ophthalmological side effects do occur due to the disease itself but have also been reported after treatment with Ivermectin: abnormal sensation in the eyes, eyelid edema, anterior uveitis, conjunctivitis, limbitis, keratitis, and chorioretinitis or choroiditis. These have rarely been severe or associated with loss of vision and have generally resolved without corticosteroid treatment.
Onchocerciasis Conjunctival hemorrhage.
All Indications: Hypotension (mainly orthostatic hypotension), worsening of bronchial asthma, toxic epidermal necrolysis, Stevens-Johnson syndrome, seizures, hepatitis, elevation of liver enzymes, and elevation of bilirubin.